Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - acetylcysteine 200 mg - oral powder - 200 mg - acetylcysteine 200 mg - acetylcysteine

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - acetylcysteine 600 mg - granules for oral solution - 600 mg - acetylcysteine 600 mg - acetylcysteine

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - acetylcysteine 600 mg - oral powder - 600 mg - acetylcysteine 600 mg - acetylcysteine

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - acetylcysteine 200 mg - oral powder - 200 mg - acetylcysteine 200 mg - acetylcysteine

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - acetylcysteine 600 mg - effervescent tablet - 600 mg - acetylcysteine 600 mg - acetylcysteine

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - acetylsalicylic acid 100 mg - gastro-resistant tablet - 100 mg - acetylsalicylic acid 100 mg - acetylsalicylic acid

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

exela pharma sciences, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine injection is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and mi

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

sagent pharmaceuticals - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and miscarriage

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

indoco remedies limited - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine injection is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and mi

Īrija - angļu - HPRA (Health Products Regulatory Authority)

ascot laboratories (ireland) limited - acetylcysteine - effervescent tablet - mucolytics; acetylcysteine